Back to Search
Start Over
Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls.
Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls.
- Source :
-
Frontiers in neurology [Front Neurol] 2022 Jun 16; Vol. 13, pp. 908081. Date of Electronic Publication: 2022 Jun 16 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- The severe acute respiratory syndrome-corona virus type 2 (SARS-CoV-2) is the cause of human coronavirus disease 2019 (COVID-19). Since its identification in late 2019 SARS-CoV-2 has spread rapidly around the world creating a global pandemic. Although considered mainly a respiratory disease, COVID-19 also encompasses a variety of neuropsychiatric symptoms. How infection with SARS-CoV-2 leads to brain damage has remained largely elusive so far. In particular, it has remained unclear, whether signs of immune cell and / or innate immune and reactive astrogliosis are due to direct effects of the virus or may be an expression of a non-specific reaction of the brain to a severe life-threatening disease with a considerable proportion of patients requiring intensive care and invasive ventilation activation. Therefore, we designed a case-control-study of ten patients who died of COVID-19 and ten age-matched non-COVID-19-controls to quantitatively assess microglial and astroglial response. To minimize possible effects of severe systemic inflammation and / or invasive therapeutic measures we included only patients without any clinical or pathomorphological indication of sepsis and who had not been subjected to invasive intensive care treatment. Our results show a significantly higher degree of microglia activation in younger COVID-19 patients, while the difference was less and not significant for older COVID-19 patients. The difference in the degree of reactive gliosis increased with age but was not influenced by COVID-19. These preliminary data warrants further investigation of larger patient cohorts using additional immunohistochemical markers for different microglial phenotypes.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Matschke, Lahann, Krasemann, Altmeppen, Pfefferle, Galliciotti, Fitzek, Sperhake, Ondruschka, Busch, Rotermund, Schulz, Lohr, Dottermusch and Glatzel.)
Details
- Language :
- English
- ISSN :
- 1664-2295
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- Frontiers in neurology
- Publication Type :
- Academic Journal
- Accession number :
- 35785352
- Full Text :
- https://doi.org/10.3389/fneur.2022.908081